03:44 PM EST - Cardiome Pharma Corp. : reported financial results for the second quarter ended June 30, 2011. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP). The company recorded a net loss of $7.7 million ($0.13 per common share) for the three months ended June 30, 2011 (Q2-2011), compared to a net income of $4.6 million ($0.08 per common share) for the three months ended June 30, 2010. Cardiome Pharma Corp.
shares T.COM are trading down $0.49 at $3.69.
